Evidence map›Paper›PMID 41869658›Full record

ArticleFrontiers in oncology2026

Recommendations for the treatment of endometrial cancer in settings with limited resources: report from the International Gynecological Cancer Society consensus meeting.

Fernando Cotait Maluf, Francinne T Tostes, Henrique Alkalay Helber, Ligia A Maluf, Juliana Karassawa Helito, Renato Moretti Marques, Graziela Z Dal Molin, Bruno Roberto Braga Azevedo, David Isla Ortiz, David Cantu and 28 more

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors.

Fernando Cotait MalufAlbert Einstein Israelita Hospital, São Paulo, Brazil.
Francinne T TostesAlbert Einstein Israelita Hospital, São Paulo, Brazil.
Henrique Alkalay HelberAlbert Einstein Israelita Hospital, São Paulo, Brazil.
Ligia A MalufAlbert Einstein Israelita Hospital, São Paulo, Brazil.
Juliana Karassawa HelitoAlbert Einstein Israelita Hospital, São Paulo, Brazil.
Renato Moretti MarquesAlbert Einstein Israelita Hospital, São Paulo, Brazil.
Graziela Z Dal MolinBeneficiência Portuguesa (BP) - Mirante Hospital, São Paulo, Brazil.
Bruno Roberto Braga AzevedoDepartment of Surgical Oncology, Oncoclínicas, Curitiba, Brazil.
David Isla OrtizDepartment of Oncological Gynecology, National Institute of Cancerology, Mexico City, Mexico.
David CantuDepartment of Oncological Gynecology, National Institute of Cancerology, Mexico City, Mexico.
Agnaldo Lopes Silva FilhoFederal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Angélica Nogueira RodriguesFederal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Reitan RibeiroDepartment of Surgical Oncology, Erasto Gaertner Hospital, Curitiba, Brazil.
Georgia Fontes CintraAlbert Einstein Israelita Hospital, São Paulo, Brazil.
Gustavo GuitmannBrazilian National Cancer Institute, Rio de Janeiro, Brazil.
Andreia Cristina de MeloBrazilian National Cancer Institute, Rio de Janeiro, Brazil.
Eduardo PaulinoBrazilian National Cancer Institute, Rio de Janeiro, Brazil.
Glauco BaiocchiGynecologic Oncology, Antonio Cândido de Camargo Cancer Center, São Paulo, SP, Brazil.
Leandro Santos de Araujo ResendeDepartment of Surgical Oncology, Oncoclínicas, Brasilia, DF, Brazil.
Michelle Samora de AlmeidaFederal University of Sao Paulo, Sao Paulo, Brazil.
Diocesio PintoInORP Group Oncoclínicas, Ribeirão Preto, Brazil.
Julio Lau de la VegaGYNECARE Women's Health Clinic, Guatemala City, Guatemala.
Florencia NollSanatorio Allende Cerro, Cordoba City, Argentina.
Juliana RodriguezNational Cancer Institute (INC), Bogotá, Colombia.
Fabio FinCentro de Oncologia do Paraná, Paraná, Brazil.
Andre LopesGynecologic Oncology, Antonio Cândido de Camargo Cancer Center, São Paulo, SP, Brazil.
Miguel Enrique Matute CorreaOnco Prevee, Lima, Peru.
Joseph S NgDivision of Gynecologic Oncology, National University Cancer Institute, Singapore, Singapore.
Daniel SanabriaHospital de San Jose Fundación Universitaria de Ciencias de la Salud Bogotá, Bogotá, Colombia.
Gabriel RendonGynecologic Oncology, Instituto de Cancerología, Bogotá, Colombia.
Fernando HerediaOncología Ginecológica en el Instituto Clínico de la Fundación Arturo López Pérez, Providência, Chile.
Ana Paula E Galerani LopesSultan Qaboos Cancer Care and Comprehensive Centre em Mascate, Seeb, Oman.
Myriam Beatriz Perotta MussiHospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Marcin Stanisław BobińskiIndependent Laboratory of Translational Medicine, Department of Clinical Genetics, Medical University of Lublin, Lublin, Poland.
Milagros Perez QuintanillaGynecologic Oncology and Breast Cancer at Medical Center ABC, Mexico City, Mexico.
Jimena MeymarKenes Group, Geneva, Switzerland.
David AtallahHôtel Dieu de France University Hospital, Women's Cancer Institute, Saint Joseph University, Beirut, Lebanon.
Audrey TsunodaHCor, Ecomedical Center, Hospital Erasto Gaertner, PUCPR, Curitiba, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Given the high disparities present in cancer care worldwide and even more challenging infrastructure and access for low- and middle-income countries, adhering precisely to international guidelines has become a challenging and complex task. Recommendations from an independent multidisciplinary panel of experts from 13 countries, including medical oncologists, pathologists, surgeons, and radiation oncologists, who met during IGCS to address some of these challenges. Methods: The panel met in New York City in September of 2022 during the International Gynecological Cancer Society Congress and was composed of specialists from developing countries in Africa, Asia, Eastern Europe, Latin America, and the Middle East. The panel addressed 103 questions and provided recommendations for the management of early, locally advanced, recurrent, and/or metastatic endometrial cancer. The questions were carefully developed by the group and specifically directed to, and answered by, specialists according to their respective areas of expertise. Consensus was defined as at least 75% of the voting members selecting a particular recommendation, whereas a majority vote was considered when one option garnered between 50.0% and 74.9% of votes. Resource limitation was defined as any issues limiting access to qualified surgeons, contemporary imaging or radiation-oncology techniques, antineoplastic drugs, or funding for providing modern medical care. Results: Eighteen of the 109 (16.5%) questions presented to the panel reached consensus, whereas a majority vote was reached for 43 (39.4%) additional questions. The recommendations for the remaining questions were considerably heterogeneous and were considered experts opinion only. Conclusion: Establishing guidelines with recommendations in areas with resource limitations may help healthcare providers and improve patient care around the world.

Indexed as

consensusendometrial cancerguidelinegynecological cancergynecological malignancieslow resources countriesresource limitationresource-stratified guidelines

Identifiers

PMID41869658
PMCPMC13002782

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.